Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Verweij

Showing results (211-220 of 655) with videos related to

Pageof 66
Sort By:
International Journal of Medical Microbiology : IJMM|July 19, 2003
Detection of Cyclospora cayetanensis in travellers returning from the tropics and subtropics using microscopy and real-time PCRJaco J Verweij, Daphne Laeijendecker, Eric A T Brienen, et al.
The American Journal of Tropical Medicine and Hygiene|August 13, 2004
Genetic substructuring within Oesophagostomum bifurcum (Nematoda) from human and non-human primates from Ghana based on random amplified polymorphic DNA analysisJohanna M de Gruijter, Juventus Ziem, Jaco J Verweij, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Phase II studies of docetaxel in the treatment of various solid tumours. EORTC Early Clinical Trials Group and the EORTC Soft Tissue and Bone Sarcoma GroupJ Verweij, G Catimel, A Sulkes, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 1996
Phase II study of a closely spaced ifosfamide--cisplatin schedule with the addition of G-CSF in advanced non-small-cell lung cancer and malignant melanomaA S Planting, R de Wit, M E van der Burg, et al.
Journal of Clinical Microbiology|November 8, 2003
Detection and identification of entamoeba species in stool samples by a reverse line hybridization assayJaco J Verweij, Daphne Laeijendecker, Eric A T Brienen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1993
Phase II study of oral administration of etoposide for patients with well- and moderately-differentiated adenocarcinomas of unknown primary siteA van der Gaast, S C Henzen-Logmans, A S Planting, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 1, 1991
The 5-HT3 receptor antagonist ondansetron re-establishes control in refractory emesis induced by non-cisplatin chemotherapyC Seynaeve, P H de Mulder, E Lane-Allman, et al.
The Netherlands Journal of Medicine|June 26, 2007
Fatal disseminated toxoplasmosis after liver transplantation: improved and early diagnosis by PCRN Vaessen, J J Verweij, I J B Spijkerman, et al.
British Journal of Cancer|February 1, 1993
Oral piritrexim, an effective treatment for metastatic urothelial cancerR de Wit, S B Kaye, J T Roberts, et al.
Cancer Chemotherapy and Pharmacology|March 6, 1998
Synergistic cytotoxicity of cisplatin and topotecan or SN-38 in a panel of eight solid-tumor cell lines in vitroJ Ma, M Maliepaard, K Nooter, et al.
Pageof 66

Showing results (211-220 of 655) with videos related to

Sort By:
Pageof 66
International Journal of Medical Microbiology : IJMM|July 19, 2003
Detection of Cyclospora cayetanensis in travellers returning from the tropics and subtropics using microscopy and real-time PCRJaco J Verweij, Daphne Laeijendecker, Eric A T Brienen, et al.
The American Journal of Tropical Medicine and Hygiene|August 13, 2004
Genetic substructuring within Oesophagostomum bifurcum (Nematoda) from human and non-human primates from Ghana based on random amplified polymorphic DNA analysisJohanna M de Gruijter, Juventus Ziem, Jaco J Verweij, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Phase II studies of docetaxel in the treatment of various solid tumours. EORTC Early Clinical Trials Group and the EORTC Soft Tissue and Bone Sarcoma GroupJ Verweij, G Catimel, A Sulkes, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 1996
Phase II study of a closely spaced ifosfamide--cisplatin schedule with the addition of G-CSF in advanced non-small-cell lung cancer and malignant melanomaA S Planting, R de Wit, M E van der Burg, et al.
Journal of Clinical Microbiology|November 8, 2003
Detection and identification of entamoeba species in stool samples by a reverse line hybridization assayJaco J Verweij, Daphne Laeijendecker, Eric A T Brienen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1993
Phase II study of oral administration of etoposide for patients with well- and moderately-differentiated adenocarcinomas of unknown primary siteA van der Gaast, S C Henzen-Logmans, A S Planting, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 1, 1991
The 5-HT3 receptor antagonist ondansetron re-establishes control in refractory emesis induced by non-cisplatin chemotherapyC Seynaeve, P H de Mulder, E Lane-Allman, et al.
The Netherlands Journal of Medicine|June 26, 2007
Fatal disseminated toxoplasmosis after liver transplantation: improved and early diagnosis by PCRN Vaessen, J J Verweij, I J B Spijkerman, et al.
British Journal of Cancer|February 1, 1993
Oral piritrexim, an effective treatment for metastatic urothelial cancerR de Wit, S B Kaye, J T Roberts, et al.
Cancer Chemotherapy and Pharmacology|March 6, 1998
Synergistic cytotoxicity of cisplatin and topotecan or SN-38 in a panel of eight solid-tumor cell lines in vitroJ Ma, M Maliepaard, K Nooter, et al.
Pageof 66